Binding Site | Homepage

iStopMM

Find out more about this landmark study to screen all adults over the age of 40 in Iceland, with the aim of preventing Myeloma before it develops

Find out more

Ola Landgren, MD, PhD

Discusses the clinical significance of free light chain testing for MGUS and Multiple Myeloma

^{_{Some of the subject matter and data contained or addressed in this session may involve off-label or forward-looking use of our products.

This video is for educational purposes only.}}

Support clinicians by offering guideline recommended Freelite® assays
with SPE and IFE for your lab’s Multiple Myeloma testing.
Freelite + SPE + IFE provides >99% diagnostic
sensitivity to identify Multiple Myeloma.

Learn More about Guideline Action Initiative

College of American Pathologists (CAP) Guidelines Webinar

College of American Pathologists (CAP) Guidelines Webinar

Join us for a webinar on the CAP Guidelines for the Laboratory Detection and the Initial Diagnosis of Monoclonal Gammopathies with Dr. David Keren, Professor of Pathology at the University of Michigan (Michigan Medicine)

The Binding Site story

Binding Site provides specialist diagnostic products to clinicians and laboratory professionals worldwide. Our people are dedicated to improving patient lives, delivering innovative medical solutions that improve the diagnosis and management of blood cancers and immune system disorders.

Smart Solutions

The Binding Site offers the smart solution for your laboratory; providing specialist diagnostic assays, instrumentation and support, worldwide. Find out more about our smart solution in protein diagnostics.

Explore our solutions